{"nct_id":"NCT05083169","title":"A Study of Teclistamab in Combination With Daratumumab Subcutaneously (SC) (Tec-Dara) Versus Daratumumab SC, Pomalidomide, and Dexamethasone (DPd) or Daratumumab SC, Bortezomib, and Dexamethasone (DVd) in Participants With Relapsed or Refractory Multiple Myeloma","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-07","start_date":"2021-10-14","start_date_type":"ACTUAL","primary_completion_date":"2025-08-01","primary_completion_date_type":"ESTIMATED","completion_date":"2028-12-08","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["JNJ"]}